Диссертация (1150288), страница 19
Текст из файла (страница 19)
V. 14. P. 492-500.62. Georgi K., Boos K. Multidimensional On-Line SPE for Undisturbed LC-MS-MSAnalysis of Basic Drugs in Biofluids // Chromatographia. 2006. V. 63. P. 523531.63. Santos-Neto A., Bergquist J., Lancas F., Sjöberg P. Simultaneous analysis of fiveantidepressant drugs using direct injection of biofluids in a capillary restrictedaccess media-liquid chromatography–tandem mass spectrometry system // J.Chromatogr. A. 2008. V. 1189. P. 514-522.64. Stokvis E., Rosing H., Beijnen J. Stable isotopically labeled internal standards inquantitative bioanalysis using liquid chromatography/mass spectrometry:necessity or not? // Rapid Commun.
Mass Spectrom. 2005. V. 19. P. 401-407.14065. Jemal M., Schuster A., Whigan D. Liquid chromatography/tandem massspectrometry methods for quantitation of mevalonic acid in human plasma andurine: method validation, demonstration of using a surrogate analyte, anddemonstration of unacceptable matrix effect in spite of use of a stable isotopeanalog internal standard // Rapid Commun. Mass Spectrom. 2003. V. 17. P. 17231734.66. Wang S., Cyronak M., Yang E. Does a stable isotopically labeled internalstandard always correct analyte response?: A matrix effect study on a LC/MS/MSmethod for the determination of carvedilol enantiomers in human plasma // J.Pharm. Biomed. Anal.
2007. V. 43. P. 701-707.67. Briscoe C., Stiles M., Hage D. System suitability in bioanalytical LC/MS/MS //J. Pharm. Biomed. Anal. 2007. V. 44. P. 484-491.68. Tan A., Hussain S., Musuku A., Massé R. Internal standard response variationsduring incurred sample analysis by LC–MS/MS: Case by case trouble-shooting //J. Chromatogr.
B. 2009. V. 877. P. 3201-3209.69. Mišl’anová C., Hutta M. Role of biological matrices during the analysis of chiraldrugs by liquid chromatography // J. Сhromatogr. B. 2003. V. 797. Р. 91-109.70. Kataoka H., Saito K. Recent advances in SPME techniques in biomedicalanalysis // J. Pharm.Biomed. Anal. 2011. V. 54.
P. 926–950.71. Yacoub M., Abuawwad A., Alawi M., Arafat T. Simultaneous determination ofamlodipine and atorvastatin with its metabolites; ortho and para hydroxyatorvastatin; in human plasma by LC–MS/MS // J.Chromatogr.B. 2013. V. 917–918. P. 36– 47.72. Parekh J., Sanyal M., Yadav M., Shrivastav P. Investigation of ex vivo stabilityof fesoterodine in human plasma and its simultaneous determination togetherwith its active metabolite 5-HMT by LC–ESI-MS/MS: Application to abioequivalence study // J.Chromatogr.
B. 2013. V. 913– 914. P. 1– 11.14173. Sharma P., Patel D., Sanyal M., Berawala H., Guttikar S., Shrivastav P.Simultaneous analysis of oxybutynin and its active metabolite N-desethyloxybutynin in human plasma by stable isotope dilution LC–MS/MS to support abioequivalence study // J.Pharm.Biomed.Anal. 2013. V. 84. P. 244– 255.74. Wagner-Redeker W., Finsterwald I., Dingemanse J.
Validation of an LC-MS/MSmethod for the quantitative determination of the orexin receptor antagonistalmorexant and its four primary metabolites in human plasma // J.Chromatogr.B.2014. V. 951–952. P. 96–103.75. Polagani S., Pilli N., Gajula R., Gandu V. Simultaneous determination ofatorvastatin, metformin and glimepiride in human plasma by LC–MS/MS and itsapplication to a human pharmacokinetic study // J.Pharm.Anal. 2013 V.3(1). P.9–19.76. Veeraraghavan S., Thappali S., Viswanadha S., Chennupati S., Nalla S., GollaM., Vakkalanka S., Rangasamy M. Simultaneous quantification of ruxolitinib andnilotinib in rat plasmaby LC–MS/MS: Application to a pharmacokinetic study //J.Pharm.Biomed.Anal. 2014.
V. 94. P. 125–131.77. Singh B., Lokhandae R.S., Dwivedi A., Sharma S., Dubey N. Improvedsimultaneous quantitation of candesartan and hydrochlorthiazide in humanplasma by UPLC–MS/MS and its application in bioequivalence studies //J.Pharm.Anal. 2014. V.4(2). P.144-152.78. Ansermot N., Brawand-Amey M., Kottelat A., Eap C. Fast quantification of tenpsychotropic drugs and metabolites in human plasma by ultra-high performanceliquid chromatography tandem mass spectrometry for therapeutic drugmonitoring // J.Chromatogr. A. 2013.
V. 1292. P.160– 172.79. Nemoto T., Lee X., Kumazawa T., Hasegawa C., Fujishiro M., Marumo A.,Shouji Y., Inagaki K., Sato K. High-throughput determination of nonsteroidalanti-inflammatorydrugsinhumanJ.Pharm.Biomed.Anal. 2014 .V.88. P. 71–80.plasmabyHILIC-MS/MS//14280. Djerada Z., Feliu C., Tournois C., Vautier D., Binet L., Robinet A., Marty H.,Gozalo C., Lamiable D., Millart H. Validation of a fast method for quantitativeanalysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevirand 10 other antiretroviral agents in human plasma samples with a new UPLCMS/MS technology // J.Pharm.Biomed.Anal. 2013.
V. 86. P. 100–111.81. Diao X., Ma Z., Wang H., Zhong D., Zhang Y., Jin J., Fan Y., Chen X.Simultaneous quantitation of 3-n-butylphthalide (NBP) and its four majormetabolites in human plasma by LC–MS/MS using deuterated internal standards// J.Pharm.Biomed.Anal. 2013. V. 78–79. P. 19–26.82. Zhao L., Zhao Y., Li Q., Chen X., Xiao F., He B., Wang J., Bi K.
A fast,sensitive, and high throughput method for the determination of cefuroxime lysinein dog plasma by UPLC–MS/MS // Talanta. 2012. V. 89. P. 84–90.83. Heinig K., Wirz T., Bucheli F., Monin V., Gloge A. Sensitive determination of apharmaceutical compound and its metabolites in human plasma by ultra-highperformance liquid chromatography–tandem mass spectrometry with on-linesolid-phase extraction // J.Pharm.Biomed.Anal.
2011. V. 54. P. 742–749.84. Zha W., Shum L. Simultaneous determination of oxymorphone and its activemetabolite 6-OH-oxymorphone in human plasma by high performance liquidchromatography–tandem mass spectrometry // J.Chromatogr. B. 2012. V. 902. P.116–121.85.
Sun L., Forni S., Schwartz M., Breidinger S., Woolf E. Quantitativedetermination of odanacatib in human plasma using liquid–liquid extractionfollowed by liquid chromatography–tandem mass spectrometry analysis //J.Chromatogr. B. 2012. V. 885– 886. P. 15–23.86. Li P., Gong Y., Lim H., Jian W., Edom R., Salter R., Silva J., Weng N.
Biogeneration of stable isotope labeled internal standards for absolute and relativequantitation of drug metabolites in plasma samples by LC–MS/MS //J.Chromatogr. B. 2013. V. 926. P. 92–100.14387. Toyoka T. LC–MS determination of bioactive molecules based upon stableisotope-coded derivatization method // J.Pharm.Biomed.Anal. 2012. V. 69.P. 174– 184.88. Zeng W., Xu Y., Constanzer M., Woolf E.J.
Determination of sitagliptininhuman plasma using protein precipitation and tandem mass spectrometry //J.Chromatogr. B. 2010. V. 878. P. 1817–1823.89. Nudel B.C., Perdoménico C., Iácono R., Cascone O. Optimization by factorialanalysisofcaprylicacidprecipitationofnon-immunoglobulinsfromhyperimmune equine plasma for antivenom preparation // Toxicon. 2012. V. 59.P. 68–73.90. Nfor B.K., Hylkema N.N., Wiedhaup K.R., Verhaert P.D.E.M., Wielen L.A.M.,Ottens M.
High-throughput protein precipitation and hydrophobic interactionchromatography: Salt effects and thermodynamic interrelation // J.Chromatogr.A. 2011. V. 1218. P. 8958– 8973.91. Gradinaru J., Vullioud A., Eap C., Ansermot N. Quantification of typicalantipsychoticsinhumanplasmabyultra-highperformanceliquidchromatography tandem mass-spectrometry for therapeutic drug monitoring //J.Pharm.Biomed.Anal. 2014. V. 88. P. 36–44.92.
Luthi G., Blangy V., Eap C., Ansermot N. Buprenorphine and norbuprenorphinequantification in human plasma by simple protein precipitation and ultra-highperformanceliquidchromatographytandemmassspectrometry//J.Pharm.Biomed.Anal. 2013. V. 77. P. 1–8.93. Noetzli M., Ansermot N., Dobrinas M., Eap C. Simultaneous determination ofantidementia drugs in human plasma: Procedure transfer from HPLC–MS toUPLC–MS/MS // J.Pharm.Biomed.Anal.
2012. V. 64– 65. P. 16–25.94. El-Bagari R.I., Azzazy H.M.E., ElKady E.F., Farouk F. Simultaneousdetermination of sildenafil citrate and some nitric oxide releasing drugs in humanplasma using UPLC MS/MS // 2014. In Press.14495. Szultka M., Krzeminski R., Szeliga J., Jackowski M., Buszewski B. A newapproach for antibiotic drugs determination in human plasma by liquidchromatography–mass spectrometry // J.Chromatogr.A.
2013. V. 1272. P. 41–49.96. Navarrete A., Martinez-Alcazar M., Duran I., Calvo E., Valenzuela B., BarbasC., Garcia A. Simultaneous online SPE–HPLC–MS/MS analysis of docetaxel,temsirolimus and sirolimus in whole blood and human plasma // J.Chromatogr.B.2013. V. 921– 922. P. 35– 42.97. Casas M., Hansen M., Krogh K., Styrishave B., Bjorklund E. Analytical samplepreparation strategies for the determination of antimalarial drugs in human wholeblood, plasma and urine // J.Chromatogr.B.
In Press.98. Dawidowicz A. L., Fornal E., Fijalkowska A. Problems in the Analysis ofPropofol in Blood when Protein Precipitation is Used in Sample Preparation //Chromatogr. 1998. V.47. P. 523-528.99. Polson C., Sarkar P., Incledon B., Raguvaran V., Grant R. Optimization ofprotein precipitation based upon effectiveness of protein removal and ionizationeffect in liquid chromatography–tandem mass spectrometry // J.Chromatogr.B.2003. V.
785. P. 263–275.100. Naidong W., Bu H., Chen Y.L., Shou W.Z.J.X., Halls T.D.J. Simultaneousdevelopment of six LC–MS–MS methods for the determination of multipleanalytes in human plasma // J. Pharm. Biomed. Anal. 2002. V. 28. P. 1115–1126101. Bedor D.C.G., Filho J.H.S., Ramos V.L.S., Gonçalves T.M., Santana C.E.M. Asensitive and robust LC-MS/MS method with monolithic column andelectrospray ionization for the quantitation of efavirenz in human plasma:application to a bioequivalence study // Quim.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
